• Português
X
  • A smartphone app to monitor cancer patients

    03 de agosto de 2021

    The platform is used by several hospitals, has more than 2,500 users, and performs 800 care processes per month on average.

  • Brazilian company develops and exports DNA polymerases

    20 de julho de 2021

    With FAPESP's support, Cellco created a novel process to produce enzymes used in DNA manipulation in vitro, including cloning, sequencing and mutagenesis, among other techniques, with applications in medical diagnostics and forensic analysis based on genetic material

  • Biodressing made from stem cells permits smart treatment of wounds and burns

    13 de julho de 2021

    Developed by startup In Situ from stem cells and a hydrogel, the product is bioprinted and placed lightly on the skin.

  • Project to create innovation districts in São Paulo state makes progress

    06 de julho de 2021

    Researchers have completed the first stage of a technical study on the creation of environments designed to foster the development of innovative solutions and creativity in the cities of São Paulo and Campinas.

  • FAPESP-funded startups are developing COVID-19 vaccines

    29 de junho de 2021

    Candidate vaccines should begin tests with animals this year.

  • Drone-borne radar monitors sugarcane growth

    08 de junho de 2021

    The system, developed by a startup supported by FAPESP, in partnership with researchers at the University of Campinas, helps plantation managers choose the optimal time to harvest the crop.

  • Company develops paper that inactivates novel coronavirus

    01 de junho de 2021

    Packaging paper and corrugated cardboard eliminate 99.99% of viral particles in up to 10 minutes of contact.

  • Nanoparticles extend shelf life of fruit and flowers

    25 de maio de 2021

    A solution developed by a startup based in São Paulo state combines fungicidal action and delayed ripening. The researchers who founded the startup took part in the 17th edition of the PIPE High-Tech Entrepreneurial Training Program.

  • Six new artificial intelligence research centers announced in call issued by FAPESP with partners

    11 de maio de 2021

    A call for proposals issued jointly with the Ministry of Science, Technology and Innovation and the Brazilian Internet Steering Committee selected the new research centers, which will focus on health, agriculture, manufacturing, and smart cities.

  • Non-invasive sensor shows correlation between blood pressure and intracranial pressure

    04 de maio de 2021

    The discovery, made possible by a partnership between a research group and a startup in São Paulo state (Brazil), could lead to novel treatments for intracranial hypertension and its complications, such as stroke.

  • Technology reduces need for extracorporeal ventilation in patients with acute respiratory failure by 80%

    12 de abril de 2021

    An electrical impedance tomography system developed by a Brazilian company enabled critical care staff at a hospital run by Harvard University to adopt individualized mechanical ventilation strategies and reduced the need for extracorporeal membrane oxygenation (ECMO) therapy.

  • São Paulo-based startup creates sustainable method of producing cosmetics

    06 de abril de 2021

    With support from FAPESP via its program to fund innovative research, the startup has developed a rejuvenating serum based on bioactives obtained from sweet wormwood, a plant used in traditional Chinese medicine.

  • Brazilian startup develops rapid test to diagnose bladder cancer

    30 de março de 2021

    Inexpensive test is non-invasive and based on detection of bladder cancer biomarkers in urine.

  • Brazilian company develops low-cost mechanical ventilators

    23 de março de 2021

    Machines designed and prototyped by Setup Automação with PIPE-FAPESP’s support could come to market costing 25% less than currently available devices.

  • Brazilian startup develops remotely operated room sterilization device

    09 de março de 2021

    The technology uses ultraviolet-C, which can inactivate the novel coronavirus. Startup BioLambda was supported by FAPESP and partnered with the Albert Einstein Jewish-Brazilian Hospital in São Paulo.

11 12 13 14 15 16 17
Fomento à Pesquisa Bolsas Auxílios Programas Como submeter propostas Dúvidas Frequentes Escritórios de Apoio (EAIP) Liberação de Recursos Prestação de Contas Sistemática de Análise Importação e Exportação SAGe Agilis SIAF
Agência FAPESP Revista Pesquisa FAPESP Reportagens sobre o PIPE Reportagens sobre o PITE
Outros sites FAPESP Biblioteca Virtual CEPID Ciência Aberta Eventos FAPESP na mídia
Fale com Pesquisa para Inovação Converse com a FAPESP